Identification of a unique urinary biomarker profile in patients with autosomal dominant polycystic kidney disease (Q51739894)

11 April 2018

title

Identification of a unique urinary biomarker profile in patients with autosomal dominant polycystic kidney disease (English)

1 reference

11 April 2018

autosomal dominant polycystic kidney disease

main subject

biomarker

0 references

patient

0 references

0 references

autosomal dominant polycystic kidney

1 reference

1 reference

11 April 2018

author name string

Andreas D Kistler

1 reference

11 April 2018

Diane Poster

1 reference

11 April 2018

Mohammed Dakna

1 reference

11 April 2018

Rudolf P Wüthrich

1 reference

11 April 2018

Andreas L Serra

1 reference

11 April 2018

language of work or name

English

0 references

publication date

1 April 2009

1 reference

11 April 2018

published in

Kidney International

1 reference

11 April 2018

volume

1 reference

11 April 2018

issue

1 reference

11 April 2018

page(s)

89-96

1 reference

11 April 2018

Epidemiology of adult polycystic kidney disease, Olmsted County, Minnesota: 1935-1980.

cites work

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.93

7 January 2021

Polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.93

7 January 2021

Comparison of phenotypes of polycystic kidney disease types 1 and 2. European PKD1-PKD2 Study Group

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.93

7 January 2021

Polycystic kidney disease: The complete structure of the PKD1 gene and its protein

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.93

7 January 2021

PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.93

7 January 2021

Advances in urinary proteome analysis and biomarker discovery

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.93

7 January 2021

Capillary electrophoresis coupled to mass spectrometry for clinical diagnostic purposes

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.93

7 January 2021

Online coupling of capillary electrophoresis with mass spectrometry for the identification of biomarkers for clinical diagnosis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.93

7 January 2021

Capillary electrophoresis coupled to mass spectrometer for automated and robust polypeptide determination in body fluids for clinical use

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.93

7 January 2021

Urine protein patterns can serve as diagnostic tools in patients with IgA nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.93

7 January 2021

Urinary proteomics in diabetes and CKD

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.93

7 January 2021

Predicting the clinical outcome of congenital unilateral ureteropelvic junction obstruction in newborn by urinary proteome analysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.93

7 January 2021

Pilot study of capillary electrophoresis coupled to mass spectrometry as a tool to define potential prostate cancer biomarkers in urine

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.93

7 January 2021

Discovery and validation of new protein biomarkers for urothelial cancer: a prospective analysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.93

7 January 2021

Repetitive fragmentation products of albumin and alpha1-antitrypsin in glomerular diseases associated with nephrotic syndrome.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.93

7 January 2021

Exosomal Fetuin-A identified by proteomics: a novel urinary biomarker for detecting acute kidney injury

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.93

7 January 2021

Urine biomarkers predict the cause of glomerular disease.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.93

7 January 2021

Proteomic patterns established with capillary electrophoresis and mass spectrometry for diagnostic purposes

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.93

7 January 2021

Clinical proteomics: A need to define the field and to begin to set adequate standards

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.93

7 January 2021

Evaluation of ultrasonographic diagnostic criteria for autosomal dominant polycystic kidney disease 1.

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.93

7 January 2021

Variation in age at ESRD in autosomal dominant polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.93

7 January 2021

Electrophoretic methods for analysis of urinary polypeptides in IgA-associated renal diseases

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.93

7 January 2021

Body fluid proteomics for biomarker discovery: lessons from the past hold the key to success in the future

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.93

7 January 2021

Elevation of serum levels of metalloproteinase-1, tissue inhibitor of metalloproteinase-1 and type IV collagen, and plasma levels of metalloproteinase-9 in polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.93

7 January 2021

A possible role for metalloproteinases in renal cyst development

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.93

7 January 2021

Sirolimus ameliorates the enhanced expression of metalloproteinases in a rat model of autosomal dominant polycystic kidney disease

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.93

7 January 2021

Type I and type III collagen mRNA levels in kidney regions of old and young rats

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.93

7 January 2021

Effect of age and biopsy site on extracellular matrix mRNA and protein levels in human kidney biopsies

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.93

7 January 2021

Transcriptional analysis of the molecular basis of human kidney aging using cDNA microarray profiling

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.93

7 January 2021

Analysis of the C-terminal structure of urinary Tamm-Horsfall protein reveals that the release of the glycosyl phosphatidylinositol-anchored counterpart from the kidney occurs by phenylalanine-specific proteolysis

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.93

7 January 2021

Tamm-Horsfall glycoprotein: biology and clinical relevance

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.93

7 January 2021

Human Tamm-Horsfall glycoprotein: urinary and plasma levels in normal subjects and patients with renal disease determined by a fully validated radioimmunoassay

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.93

7 January 2021

Determinants of urinary excretion of Tamm-Horsfall protein in non-selected kidney stone formers and healthy subjects

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.93

7 January 2021

Mutations of the UMOD gene are responsible for medullary cystic kidney disease 2 and familial juvenile hyperuricaemic nephropathy

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.93

7 January 2021

Increases in kidney volume in autosomal dominant polycystic kidney disease can be detected within 6 months

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.93

7 January 2021

Capillary electrophoresis coupled to mass spectrometry to establish polypeptide patterns in dialysis fluids

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.93

7 January 2021

Practical points in urinary proteomics

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.93

7 January 2021

Discovery of biomarkers in human urine and cerebrospinal fluid by capillary electrophoresis coupled to mass spectrometry: towards new diagnostic and therapeutic approaches

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.93

7 January 2021

Mass spectrometry for the detection of differentially expressed proteins: a comparison of surface-enhanced laser desorption/ionization and capillary electrophoresis/mass spectrometry

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.93

7 January 2021

Identifying differentially expressed genes using false discovery rate controlling procedures

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.93

7 January 2021

Biomarker discovery by CE-MS enables sequence analysis via MS/MS with platform-independent separation

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.93

7 January 2021

Electron transfer dissociation of peptide anions

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.93

7 January 2021

Advancing proteomics with ion/ion chemistry

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.93

7 January 2021

Peptide and protein sequence analysis by electron transfer dissociation mass spectrometry

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.93

7 January 2021

Performance characteristics of electron transfer dissociation mass spectrometry

1 reference

https://api.crossref.org/works/10.1038%2FKI.2009.93

7 January 2021

Identifiers

DOI

10.1038/KI.2009.93

1 reference

11 April 2018

1 reference

11 April 2018